Merus Eulerpool Nyheder

Merus Aktie Nyheder

Merus bliver overvåget af mange journalister og investorer over hele verden. De seneste Merus nyheder samler vi her.

• 7. januar ·

  Yahoo
  Jim Cramer Says Merus (MRUS) Still ‘Very Speculative’
• 17. december ·

  SeekingAlpha
  Harbor Health Care ETF Q3 2024 Commentary
• 10. december ·

  Yahoo
  Merus (MRUS): FDA Approval and Speculative Future in Cancer Therapy
• 7. december ·

  Yahoo
  Merus’ Petosemtamab Monotherapy Interim Data Continues to Demonstrate Clinically Meaningful Activity in 2L+ r/m HNSCC
• 4. december ·

  Yahoo
  Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy Study
• 4. december ·

  Yahoo
  Merus price target lowered to $109 from $111 at Guggenheim
• 2. december ·

  Yahoo
  Merus Licenses US Commercialization Rights For Cancer Potential Zenocutuzumab, Analyst Highlight Merus' Pipeline
• 1. december ·

  Yahoo
  Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024
• 23. november ·

  Yahoo
  Merus NV (MRUS): Among the Most Promising Cancer Stocks According to Hedge Funds
• 20. november ·

  SeekingAlpha
  Franklin Biotechnology Discovery Fund Q3 2024 Commentary